Selin Kurnaz is co-Founder and CEO of Massive Bio, a global industry leader in connecting patients to clinical trials using artificial intelligence. An engineer, businesswoman, dealmaker, and immigrant, she founded Massive Bio to enable access to clinical trials to cancer patients around the globe regardless of their location and/or financial stability. Previously, Kurnaz was on the founding team of EY's Private Equity Value Creation, where she helped private equity companies make investment decisions in healthcare. She holds a PhD in Mechanical Engineering from the University of Michigan.
Engineers see everything as a system, know how to design under constraints, and recognize the need for trade-offs. Adopting an engineering mindset in oncology research can fix all the broken constituent processes like patient enrollment to systematize clinical trials.